- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.04. | BrainsWay expands deep TMS treatment access in Israel | 1 | Seeking Alpha | ||
| 17.04. | Brainsway Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.04. | BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS to Treat Parkinson's Disease | 80 | GlobeNewswire (Europe) | JERUSALEM and BURLINGTON, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments... ► Artikel lesen | |
| 04.04. | Brainsway Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.03. | Brainsway Ltd. - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 18.03. | BrainsWay Broadens Partnership with Katie's Way Plus Through Order of an Additional 18 Deep TMS Systems | 1 | GlobeNewswire (USA) | ||
| 18.03. | Brainsway Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.03. | Brainsway stock price target lifted at Oppenheimer on strong Q4 sales | 1 | Investing.com | ||
| 06.03. | Earnings call: BrainsWay sees robust growth, eyes international expansion | 1 | Investing.com | ||
| 06.03. | Brainsway beats top-line and bottom-line estimates; initiates FY24 outlook | 1 | Seeking Alpha | ||
| 06.03. | BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights | 119 | GlobeNewswire (Europe) | Generated Record Revenues with Robust 50% Year-over-Year Revenue Growth in Q4 2023; Generated Positive Quarterly Net Income Providing Full-Year 2024 Revenue Guidance of $37-$40 Million with Continued... ► Artikel lesen | |
| 06.03. | Brainsway Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 05.03. | BrainsWay Earnings Preview | 2 | Benzinga.com | ||
| 05.03. | Brainsway Q4 2023 Earnings Preview | 1 | Seeking Alpha | ||
| 05.03. | What's in the Offing for Brainsway (BWAY) in Q4 Earnings? | 1 | Zacks | ||
| 21.02. | BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024 | 1 | GlobeNewswire (USA) | ||
| 18.02. | New business model transforms Brainsway's fortunes | 2 | Globes | ||
| 11.01. | BrainsWay initiates new studies of non-invasive neurostim | 2 | MassDevice | ||
| 10.01. | BrainsWay Initiates Clinical Evaluation of Rotational Field "Deep TMS 360°" Technology | 1 | GlobeNewswire (USA) | ||
| 10.01. | Brainsway Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings |
Seite:
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORPEA | 13,736 | +0,94 % | ORPEA: emeis Sells a Real-Estate Portfolio in the Netherlands Worth a Total Value of Around €97 Million | Regulatory News:
ORPEA (Paris:ORP):
emeis announces that it has signed an agreement to sell a real estate portfolio of eleven nursing homes in the Netherlands to Bouwinvest for a total deed-in-hand... ► Artikel lesen | |
| NANO-X IMAGING | 8,980 | 0,00 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
| BUTTERFLY NETWORK | 0,809 | 0,00 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen | |
| GOODRX | 7,150 | 0,00 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
| JOINT CORP | 12,320 | 0,00 % | The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results | - Grew 2023 Revenue 16%, System-wide Sales 12%, and System-wide Comp Sales 4% vs. 2022 - - Increased Clinic Count to 935 at Year-end 2023, Initiating Refranchising Program - SCOTTSDALE, Ariz., March... ► Artikel lesen | |
| CARMAT | 3,050 | -0,16 % | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | 2023 sales of €2.8 million, i.e. 17 Aeson® implants, including 11 in the last quarter
2024 sales forecast of around €14 million
Active exploration of financing options to extend... ► Artikel lesen | |
| HYPERFINE | 0,820 | 0,00 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROGYNY | 32,540 | 0,00 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| BIOMERICA | 0,533 | 0,00 % | Biomerica jumps on signing multi-year distribution deal with major UAE healthcare company | ||
| MIMEDX | 6,260 | 0,00 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
| ATRION | 390,00 | +6,56 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
| ATRICURE | 23,370 | 0,00 % | AtriCure upgraded at Oppenheimer on valuation | ||
| TALKSPACE | 3,090 | 0,00 % | Talkspace Announces Third Quarter 2023 Results | B2B payor revenue grew 132% year-over-year 3Q 2023 Operating expenses of $24.0 million, down 30% year-over-year Reduced Net Loss to $4.4 million and Adjusted EBITDA1 loss to $2.8 million, an improvement... ► Artikel lesen | |
| AMWELL | 0,595 | 0,00 % | Amwell Receives Continued Listing Standard Notice From NYSE | Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York... ► Artikel lesen | |
| OUTSET MEDICAL | 2,630 | 0,00 % | FDA labels Outset Medical recall of Tablo hemodialysis system as Class I |
BRAINSWAY LTD ADR gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 5,100 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
